Targetless T cells in cancer immunotherapy

por thor Straten, Per, Garrido, Federico
Publicado 2016

Exercise and cancer: from “healthy” to “therapeutic”?

por Idorn, Manja, thor Straten, Per
Publicado 2017

Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site

por Idorn, Manja, thor Straten, Per
Publicado 2018

The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens

por thor Straten, Per, Andersen, Mads Hald
Publicado 2010

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment

por Hadrup, Sine, Donia, Marco, thor Straten, Per
Publicado 2012

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting

por Peeters, Marlies J. W., Rahbech, Anne, thor Straten, Per
Publicado 2019

Characterization of Ex Vivo Expanded Tumor Infiltrating Lymphocytes from Patients with Malignant Melanoma for Clinical Application

por Junker, Niels, thor Straten, Per, Andersen, Mads Hald, Svane, Inge Marie
Publicado 2011

T-cell clonotypes in cancer

por thor Straten, Per, Schrama, David, Andersen, Mads Hald, Becker, Jürgen C
Publicado 2004

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer

por Andersen, Mads Hald, Soerensen, Rikke B, Becker, Jürgen C, thor Straten, Per
Publicado 2006

Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10–13 October 2011, Copenhagen, Denmark

por Køllgaard, Tania, van den Berg, Joost H., Donia, Marco, thor Straten, Per
Publicado 2012

Exercise Oncology and Immuno-Oncology; A (Future) Dynamic Duo

por Holmen Olofsson, Gitte, Jensen, Agnete Witness Praest, Idorn, Manja, thor Straten, Per
Publicado 2020

Therapeutic Cancer Vaccines in Combination with Conventional Therapy

por Andersen, Mads Hald, Junker, Niels, Ellebaek, Eva, Svane, Inge Marie, thor Straten, Per
Publicado 2010

Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?

por Jensen, Agnete Witness Praest, Carnaz Simões, Ana Micaela, thor Straten, Per, Holmen Olofsson, Gitte
Publicado 2021

TAM Receptor Inhibition–Implications for Cancer and the Immune System

por Aehnlich, Pia, Powell, Richard Morgan, Peeters, Marlies J. W., Rahbech, Anne, thor Straten, Per
Publicado 2021

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers

por Holmen Olofsson, Gitte, Idorn, Manja, Khan, Wajid, Andersen, Mads Hald, Moser, Bernhard, thor Straten, Per
Publicado 2014

Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet

por Aehnlich, Pia, Carnaz Simões, Ana Micaela, Skadborg, Signe Koggersbøl, Holmen Olofsson, Gitte, thor Straten, Per
Publicado 2020

Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8(+) T Cells

por Powell, Richard M., Peeters, Marlies J. W., Rahbech, Anne, Aehnlich, Pia, Seremet, Tina, thor Straten, Per
Publicado 2021

Cancer treatment: the combination of vaccination with other therapies

por Andersen, Mads Hald, Sørensen, Rikke Bæk, Schrama, David, Svane, Inge Marie, Becker, Jürgen C., thor Straten, Per
Publicado 2008

Genetic engineering of T cells for increased homing to the tumor site

por Idorn, Manja, Holmen Olofsson, Gitte, Larsen, Hjalte List, van den Berg, Joost, Met, Özcan, thor Straten, Per
Publicado 2014

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes

por Sittig, Simone P, Køllgaard, Tania, Grønbæk, Kirsten, Idorn, Manja, Hennenlotter, Jörg, Stenzl, Arnulf, Gouttefangeas, Cécile, thor Straten, Per
Publicado 2013